Artivion | CRY - الأصول





الأصول تغيير تاريخ
Abbott USD 110.43B 23.72B 2026-03
Accuray USD 448.01M 8.81M 2025-12
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 1.07B 188.78M 2026-06
AtriCure USD 676.64M 32.66M 2026-06
Baxter International USD 19.79B 55M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Inogen USD 307.01M 5.03M 2025-09
Integra LifeSciences USD 3.56B 14.24M 2026-06
J&J USD 201.06B 167M 2026-06
Mesa Laboratories USD 434.85M 4.5M 2025-12
Orthofix International USD 873.02M 13.58M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
ResMed USD 8.97B 181.66M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Terumo JPY 2.37T 61.86B 2026-06
Trinity Biotech USD 105.16M 1.45M 2025-12